{"id":"adefovir-tablets","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Asthenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Adefovir is a nucleotide reverse transcriptase inhibitor that interferes with the viral DNA synthesis, thereby inhibiting the replication of the hepatitis B virus. This results in a decrease in viral load and a reduction in liver inflammation.","oneSentence":"Adefovir works by inhibiting the replication of the hepatitis B virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:19:31.887Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis B"},{"name":"Hepatitis B virus infection"}]},"trialDetails":[{"nctId":"NCT03491553","phase":"PHASE2","title":"Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2018-04-06","conditions":"Chronic Hepatitis B","enrollment":48},{"nctId":"NCT03241641","phase":"PHASE4","title":"Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.","status":"COMPLETED","sponsor":"Young-Suk Lim","startDate":"2017-10-26","conditions":"Chronic Hepatitis b","enrollment":174},{"nctId":"NCT01300234","phase":"PHASE3","title":"Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-03-30","conditions":"Hepatitis B","enrollment":512},{"nctId":"NCT01353742","phase":"PHASE1","title":"Lamivudine and Adefovir Dipivoxil Fixed Dose Combination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-02-21","conditions":"Hepatitis B, Chronic","enrollment":40},{"nctId":"NCT00371761","phase":"PHASE3","title":"PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-09","conditions":"Hepatitis B, Chronic (CHB)","enrollment":25},{"nctId":"NCT00116805","phase":"PHASE3","title":"A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2005-06","conditions":"Chronic Hepatitis B","enrollment":266},{"nctId":"NCT00117676","phase":"PHASE3","title":"A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2005-02","conditions":"Chronic Hepatitis B","enrollment":382},{"nctId":"NCT02598063","phase":"PHASE4","title":"A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-10","conditions":"Hepatitis B, Chronic","enrollment":255},{"nctId":"NCT00986778","phase":"PHASE4","title":"Entecavir Plus Adefovir in Lamivudine-Resistant Patients","status":"WITHDRAWN","sponsor":"Bristol-Myers Squibb","startDate":"2009-12","conditions":"Hepatitis B, Chronic","enrollment":""},{"nctId":"NCT02075294","phase":"","title":"Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Ying-Jie Ji","startDate":"2010-01","conditions":"Hepatitis B, Chronic","enrollment":242},{"nctId":"NCT01546116","phase":"PHASE4","title":"Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)","status":"COMPLETED","sponsor":"Korea University","startDate":"2010-02","conditions":"Chronic Hepatitis B","enrollment":20},{"nctId":"NCT00410202","phase":"PHASE3","title":"Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":629},{"nctId":"NCT00001082","phase":"PHASE3","title":"The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1996-12","conditions":"Cytomegalovirus Infections, HIV Infections","enrollment":505},{"nctId":"NCT00065507","phase":"PHASE3","title":"Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2003-08","conditions":"Hepatitis B","enrollment":195},{"nctId":"NCT01863589","phase":"","title":"Drug Use Investigation for HEPSERA (Adefovir) Tablet","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-02","conditions":"Hepatitis B","enrollment":436},{"nctId":"NCT01799486","phase":"PHASE4","title":"Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Lin Bingliang","startDate":"2013-02","conditions":"HBV-related Liver Cirrhosis","enrollment":300},{"nctId":"NCT00718887","phase":"PHASE4","title":"Suboptimal Responders to Adefovir Switching to Entecavir","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2008-07","conditions":"Hepatitis B, Chronic","enrollment":228},{"nctId":"NCT00095121","phase":"PHASE3","title":"Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2004-06","conditions":"Chronic Hepatitis B","enrollment":173},{"nctId":"NCT00307489","phase":"PHASE2","title":"Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2006-03","conditions":"Chronic Hepatitis B","enrollment":106},{"nctId":"NCT00376259","phase":"PHASE3","title":"Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone","status":"TERMINATED","sponsor":"Novartis","startDate":"2007-01","conditions":"Hepatitis B","enrollment":43},{"nctId":"NCT00605384","phase":"PHASE3","title":"A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection","status":"TERMINATED","sponsor":"Bristol-Myers Squibb","startDate":"2008-08","conditions":"Chronic Hepatitis B","enrollment":4},{"nctId":"NCT00753467","phase":"PHASE2","title":"A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Huntington Medical Research Institutes","startDate":"2008-09","conditions":"Hepatitis B","enrollment":30},{"nctId":"NCT00096785","phase":"PHASE3","title":"Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2004-12","conditions":"Hepatitis B, Chronic Disease","enrollment":69},{"nctId":"NCT00324961","phase":"PHASE4","title":"Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-01","conditions":"Chronic Hepatitis B","enrollment":533},{"nctId":"NCT00441974","phase":"PHASE4","title":"Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12","conditions":"Chronic Hepatitis B","enrollment":1470},{"nctId":"NCT00316719","phase":"PHASE3","title":"Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-01","conditions":"Chronic Hepatitis B","enrollment":105},{"nctId":"NCT00857675","phase":"PHASE3","title":"A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-12","conditions":"Chronic Hepatitis B","enrollment":480},{"nctId":"NCT00810524","phase":"PHASE4","title":"Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2007-01","conditions":"Hepatitis B, Chronic","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Adefovir tablets","genericName":"Adefovir tablets","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adefovir works by inhibiting the replication of the hepatitis B virus. Used for Chronic hepatitis B, Hepatitis B virus infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}